ARTICLE | Clinical News
Avandia rosiglitazone regulatory update
November 19, 2007 8:00 AM UTC
FDA and GSK plan to supplement the existing boxed warning on the label of Avandia rosiglitazone to include new language noting that it has been associated with a potential increase in the risk of myoc...